Related Reading

Related Reading

Back to Document

Through the approval of the Broward Health Institutional Review Board, Broward Health Medical Center offers pharmaceutical-sponsored FDA-approved cardiovascular clinical trials to the community. These various pharmaceutical sponsored trials involve cutting-edge cardiovascular related areas to study cardiac disease, anticoagulants or antithrombotics, blood pressure control, cholesterol control, atrial fibrillation, interventional and cardiology, and diabetes, as well as cardiac device trials.

Cardiovascular clinical trial research is done to help doctors to find a better way to treat and diagnose patients with cardiac disease. The decision to enroll in a clinical trial is completely voluntary. Each trial offers its own opportunities and risks, but many research volunteers find that clinical trials offer these common benefits:

  • opportunity for health care provided by leading physicians in the field of cardiac research
  • access to new drugs and interventions before they are widely available
  • for you to have a more active role in your own health care
  • close monitoring of your health care and any side effects
  • you may be the first to benefit, if the approach being studied is found to be helpful to the disease being studied
  • an opportunity to make a valuable contribution to cardiac research

If you think that you may qualify for a study and wish to participate, call the senior research nurses at the cardiovascular research department. Please call Broward Health Medical Center Cardiovascular Research at 954-468-5237 and leave your name and number, along with the study name that you think that you may qualify for and a research nurse will contact you.

For further information, please visit: http://www.clinicaltrials.gov/

Breast

REDUCE-IT: AMR-01-01-0019 - A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events with EPA – Intervention Trial)

Sponsor: ANTHERA
Investigator: Dr. Joel Gellman

B14181038 Phase 3 Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Evaluation of the Efficacy, Safety and Tolerability of PF-04950615, in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Sponsor: PFIZER
Investigator: Dr. David Perloff

B1481022 Phase 3 Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Evaluation of the Efficacy, Safety and Tolerability of PF-04950615, in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Sponsor: Cardiac Pacemakers, Inc. (dba Boston Scientific CRM)
Investigator: Dr. David Perloff

CLOSED TO ENROLLMENT

LSS of 4-SITE: Longitudinal Surveillance Study of the 4-SITE Lead/Header System
Sponsor: PFIZER
Investigator: Dr. Ahmed Osman

Siello IDE #G110221 (Pre-Market and Post-Approval Registry)
Sponsor: BIOTRONIK
Investigator: Dr. David Kenigsberg

STOP-AF Post-Approval Study:Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (Medtronic) (closed to enrollment)
Sponsor: MEDTRONIC
Investigator: Dr. Ahmed Osman

RESPOND-CRT Study:Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D (closed to enrollment)
Sponsor: SORIN CRM
Investigator: Dr. Ahmed Osman

Other BHMC Research Studies

Angel Catheter study IDE: G120266
QD-230: The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Sponsor: BiO2 Medical, Inc.
Investigator: Dr. Bukur

Please call the Principal Investigator or Study coordinator with any questions or potential subjects.

Back to the Top


SHARE THIS PAGE

More Information

For more information, visit clinicaltrials.gov